Trastuzumab Deruxtecan in First-line HER2-positive Locally Advanced/MBC Patients Resistant to Trastuzumab+Pertuzumab
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to AstraZeneca
Related studies linked through entity extraction aliases.
Long-term Efficacy and Safety of Tozorakimab in Participants With Chronic Obstructive Pulmonary Disease With a History of Exacerbations (PROSPERO).
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
The Fontan Dapagliflozin Pilot Study
- Status
- ENROLLING_BY_INVITATION
- Phase
- PHASE4
A Study of AZD3427 in Participants With Heart Failure and Pulmonary Hypertension Group 2
- Status
- COMPLETED
- Phase
- PHASE2
Patient-Reported Outcomes of Benralizumab in Real-World Use in Severe Eosinophilic Asthma Patients in Taiwan (BEAT)
- Status
- COMPLETED
- Phase
- N/A
TEZSPIRE (Tezepelumab) Asthma Japan Post-Marketing Study (PMS)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Incidence of COVID-19 Following Vaccination in Botswana Against SARS CoV 2
- Status
- COMPLETED
- Phase
- PHASE3
Multiple Dose Study of Safety and Pharmacokinetics of MEDI0618 in Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
eVusheld Assessment reaL wORld Effectiveness in Israel Clalit Health Services
- Status
- COMPLETED
- Phase
- N/A
Targeted Assessment in High-Risk paTients With dIAbetes to ideNtify Undiagnosed Heart Failure
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
NeoAdjuvant Therapy With Trastuzumab-deruxtecan Versus Chemotherapy+Trastuzumab+Pertuzumab in HER2+ Early Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Novel Combinations in Participants With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
- Status
- RECRUITING
- Phase
- PHASE2
SIRT With Tremelimumab and Durvalumab for Resectable HCC
- Status
- RECRUITING
- Phase
- PHASE1
Effectiveness of the Oxford-AstraZeneca COVID-19 Vaccine as a 2nd Booster, the REFORCO-Brazil Study
- Status
- COMPLETED
- Phase
- N/A
A Study to Assess Safety, Tolerability, and Pharmacokinetics of AZD0186
- Status
- TERMINATED
- Phase
- PHASE1
A Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled, Time-to-first Asthma Exacerbation Phase III Efficacy and Safety Study of Benralizumab in Paediatric Patients With Severe Eosinophilic Asthma (DOMINICA)
- Status
- RECRUITING
- Phase
- PHASE3
Evusheld Japan PMS_Japan Post-Marketing Surveillance (PMS)
- Status
- COMPLETED
- Phase
- N/A
Phase III, Open-label, First-line Study of Dato-DXd in Combination With Durvalumab and Carboplatin for Advanced NSCLC Without Actionable Genomic Alterations
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
MEDI5752 in Japanese Patients With Advanced Solid Tumors.
- Status
- COMPLETED
- Phase
- PHASE1
A French Real-life Study: EvaluatioN of durvALumab Utilization and Effectiveness for First Line Extensive Stage Small Cell Lung Cancer.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A